Project Details
Description
A Phase II, Randomized, Open-label Trial of Biweekly Pemetrexed plus Gemcitabine vs. Pemetrexed or Pemetrexed plus Carboplatin in Relapsed Non-Smal
| Status | Finished |
|---|---|
| Effective start/end date | 1/18/07 → 3/31/10 |
Funding
- Eli Lilly G.m.b.H.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.